Exviera, Viekirax


Authors: P. Urbánek
Authors‘ workplace: Interní klinika 1. LF UK a ÚVN, Praha
Published in: Gastroent Hepatol 2015; 69(1): 75-80
Category: Drug Profile
doi: 10.14735/amgh201575


Sources

1. Němeček V. Sérologický přehled ČR v roce 2001 –  virová hepatitida A, B, C. Zprávy CEM 003; 12: 55– 61.

2. World Health Organization. Global alert and response (GAR). Hepatitis C. [online]. Available from: http:/ / www.who.int/ csr/ disease/ hepatitis/ whocdscsrlyo2003/ en/ .

3. Perz JF, Armstrong GL, Farrington LA et al. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006; 45(4): 529– 538.

4. Kanwal F, Hoang T, Kramer JR et al. Increas­ing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. Gastroenterology 2011; 140(4): 1182– 1188. doi: 10.1053/ j.gastro.2010.12.032.

5. Urbánek P, Husa P, Galský J et al. Standardní dia­gnostický a terapeutický postup chronické infekce virem hepatitidy C (HCV). Čas Lék Čes 2008; 147(5): příloha: I– XII.

6. Fried MW, Shiffman ML, Reddy KR et al.Peginterferon alfa‑2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347(13): 975– 982.

7. Hadziyannis SJ, Sette H Jr, Morgan TR et al. Peginterferon‑alfa2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 2004; 140(5): 346– 355.

8. Urbánek P. Novinky v terapii chronické infekce virem hepatitidy C. Remedia 2011, 21: 380– 385.

9. Urbánek P, Husa P, Galský J et al. Standardní dia­gnostický a terapeutický postup u chronické infekce virem hepatitidy C (HCV). Gastroent Hepatol 2012; 66(3): 214– 229.

10. Viekirax SPC. North Chicago, IL: AbbVie 2014.

11. Feld JJ, Kowdley KV, Coakley E et al. Treatment of HCV with ABT‑ 450/ r‑ ombitasvir and dasabuvir with ribavirin. N Engl J Med 2014; 370(17):1594– 1603. doi: 10.1056/ NEJMoa1315722.

12. Zeuzem S, Jacobson IM, Baykal T et al. Retreatment of HCV with ABT‑ 450/ r‑ ombitasvir and dasabuvir with ribavirin. N Engl J Med 2014; 370(17): 1604– 1614. doi: 10.1056/ NEJMoa1401561.

13. Poordad F, Hezode C, Trinh R et al. ABT‑ 450/ r‑ ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis. N Engl J Med 2014; 370(21): 1973– 1982. doi: 10.1056/ NEJMoa1402869.

14. Manns MP, Foster GR, Rockstroh JK et al. The way forward in HCV treatment – finding the right path. Nat Rev Drug Discov 2007; 6(12): 991–1000.

Labels
Paediatric gastroenterology Gastroenterology and hepatology Surgery

Article was published in

Gastroenterology and Hepatology

Issue 1

2015 Issue 1

Most read in this issue
Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account